Assessment of scaffold hopping efficiency by use of molecular interaction fingerprints

Journal of Medicinal Chemistry

Volumn 51, Issue 11, 2008, Pages 3222-3229

  Venhorst, Jennifer ^a   Núñez, Sara ^a   Terpstra, Jan Willem ^a   Kruse, Chris G ^a  

^a Solvay Pharmaceuticals Inc   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

LIGAND;

ALGORITHM; ARTICLE; BAYES THEOREM; COMBINATORIAL LIBRARY; COMPARATIVE STUDY; DATA BASE; DRUG SCREENING; MOLECULAR INTERACTION; SCORING SYSTEM;

ADENOSINE DEAMINASE; ALGORITHMS; BAYES THEOREM; BINDING SITES; CHEMISTRY, PHYSICAL; DATABASES, FACTUAL; LIGANDS; MODELS, MOLECULAR; PROTEIN BINDING; RETINOID X RECEPTOR ALPHA;

EID: 44949173950     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm8001058     Document Type: Article

References (31)

1. Kraemer, O.; Hazemann, I.; Podjarny, A. D.; Klebe, G. Virtual screening for inhibitors of human aldose reductase. Proteins: Struct., Funct., Bioinf. 2004, 55, 814-823.
2. Jain, A. N. Virtual screening in lead discovery and optimization. Curr. Opin. Drug Discovery Dev. 2004, 7, 396-403.
3. Klebe, G. Virtual ligand screening: strategies, perspectives and limitations. Drug Discovery Today 2006, 11, 580-594.
4. Shoichet, B. K. Virtual screening of chemical libraries. Nature 2004, 432, 862-865.
5. Seifert, M. H.; Kraus, J.; Kramer, B. Virtual high-throughput screening of molecular databases. Curr. Opin. Drug Discovery Devel. 2007, 10, 298-307.
6. Marcou, G.; Rognan, D. Optimizing fragment and scaffold docking by use of molecular interaction fingerprints. J. Chem. Inf. Model. 2007, 47, 195-207.
7. Verdonk, M. L.; Berdini, V.; Hartshorn, M. J.; Mooij, W. T.; Murray, C. W.; Taylor, R. D.; Watson, P. Virtual screening using protein-ligand docking: avoiding artificial enrichment. J. Chem. Inf. Comput. Sci. 2004, 44, 793-806.
8. Gregori-Puigjane, E.; Mestres, J. SHED: Shannon entropy descriptors from topological feature distributions. J. Chem. Inf. Model. 2006, 46, 1615-1622.
9. Zhang, Q.; Muegge, I. Scaffold hopping through virtual screening using 2D and 3D similarity descriptors: ranking, voting, and consensus scoring. J. Med. Chem. 2006, 49, 1536-1548.
10. Barker, E. J.; Buttar, D.; Cosgrove, D. A.; Gardiner, E. J.; Kitts, P; Willett, P.; Gillet, V. J. Scaffold hopping using clique detection applied to reduced graphs. J. Chem. Inf. Model. 2006, 46, 503-511.
11. Hert, J.; Willett, P.; Wilton, D. J.; Acklin, P.; Azzaoui, K.; Jacoby, E.; Schuffenhauer, A. New methods for ligand-based virtual screening: use of data fusion and machine learning to enhance the effectiveness of similarity searching. J. Chem. Inf. Model. 2006, 46, 462-470.
12. Ahlstrom, M. M.; Ridderstrom, M.; Luthman, K.; Zamora, I. Virtual screening and scaffold hopping based on GRID molecular interaction fields. J. Chem. Inf. Model. 2005, 45, 1313-1323.
13. Zhao, H. Scaffold selection and scaffold hopping in lead generation: a medicinal chemistry perspective. Drug Discovery Today 2007, 12, 149-155.
14. Rush, T. S., III; Grant, J. A.; Mosyak, L.; Nicholls, A. A shape-based 3-D scaffold hopping method and its application to a bacterial protein-protein interaction. J. Med. Chem. 2005, 48, 1489-1495.
15. Naerum, L.; Norskov-Lauritsen, L.; Olesen, P. H. Scaffold hopping and optimization towards libraries of glycogen synthase kinase-3 inhibitors. Bioorg. Med. Chem. Lett. 2002, 12, 1525-1528.
16. Schrödinger, L. L. C., New York.
17. Jones, G.; Willett, P.; Glen, R. C.; Leach, A. R.; Taylor, R. Development and validation of a genetic algorithm for flexible docking. J. Mol. Biol. 1997, 267, 727-748.
18. Hawkins, P. C.; Skillman, A. G.; Nicholls, A. Comparison of shape-matching and docking as virtual screening tools. J. Med. Chem. 2007, 50, 74-82.
19. Irwin, J. J.; Shoichet, B. K. ZINC: A free database of commercially available compounds for virtual screening. J. Chem. Inf. Model. 2005, 45, 177-182.
20. RCSB Protein Data Bank, http://www.pdb.org.
21. Huang, N.; Shoichet, B. K.; Irwin, J. J. Benchmarking sets for molecular docking. J. Med. Chem. 2006, 49, 6789-6801.
22. Prous Science Integrity, http://www.prous.com/integrity.
23. SYBYL, Tripos International, 1699 Sout Hanley Rd., St. Louis, Missouri, 63144.
24. OMEGA, OpenEye Science Software, 3600 Cerrillos Road, Suite 1107, Santa Fe, New Mexico, 2001.
25. Bioreason, Inc., 3900 Pase del Sol, Santa Fe, New Mexico 87507 (version 3.5).
26. Deng, Z.; Chuaqui, C.; Singh, J. Knowledge-based design of target-focused libraries using protein-ligand interaction constraints. J. Med. Chem. 2006, 49, 490-500.
27. Tanimoto, T. T. IBM Internal Report; Nov. 17, 1957.
28. Hawkins, P. C.; Skillman, A. G.; Nicholls, A. Comparison of shape-matching and docking as virtual screening tools. J. Med. Chem. 2007, 50, 74-82.
29. Scitegic, 9665 Chesapeake Drive, Suite 401, San Diego, California 92123-1365.
30. Ferrari, A. M.; Wei, B. Q.; Costantino, L.; Shoichet, B. K. Soft docking and multiple receptor conformations in virtual screening. J. Med. Chem. 2004, 47, 5076-5084.
31. Egea, P. F.; Mitschler, A.; Rochel, N.; Ruff, M.; Chambon, P.; Moras, D. Crystal structure of the human RXRα ligand-binding domain bound to its natural ligand: 9-cis-retinoic acid. EMBO J. 2000, 19, 2592-2601.